Cardiotoxicity of Adjuvant Trastuzumab
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms|Heart Failure
Sponsor: Royal Prince Alfred Hospital, Sydney, Australia